Pitavastatin 4.18 mg/1 (Pitavastatin Calcium TABLET, FILM COATED) 4.18 mg/1

Pitavastatin 4.18 mg is a cholesterol-lowering medication designed to help manage lipid levels. This oral tablet is commonly used to reduce LDL cholesterol and triglycerides while increasing HDL cholesterol.

Strength

4.18 mg/1

Pack Size

90 TABLET, FILM COATED in 1 BOTTLE (0480-3633-98)

Manufacturer / TM Owner

Teva Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pitavastatin 4.18 mg is primarily used to lower cholesterol levels in the blood. It is often prescribed for individuals with high cholesterol or those at risk of cardiovascular diseases. This medication works by inhibiting an enzyme in the liver that produces cholesterol, helping to manage lipid levels and support heart health.

Side Effects

Common effects of Pitavastatin 4.18 mg may include mild digestive issues, muscle pain, or headaches. Some users might experience dizziness or fatigue. These effects vary and are not experienced by everyone.

Precautions & Warnings

Pitavastatin 4.18 mg should be taken as directed by a healthcare provider. It is important to inform your healthcare provider about any existing medical conditions or other medications you are taking. Regular monitoring of liver function may be recommended.

Avoid Interactions

Pitavastatin 4.18 mg may interact with certain medications, including other cholesterol-lowering drugs, cyclosporine, and some antibiotics. It is advisable to avoid grapefruit juice, as it can affect the medication's effectiveness. Always consult a healthcare provider before starting any new medication.

Frequently Asked Questions

Pitavastatin 4.18 mg is used to lower cholesterol levels in the blood, particularly LDL cholesterol and triglycerides, while increasing HDL cholesterol.

Pitavastatin 4.18 mg is typically taken orally, usually once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include mild digestive issues, muscle pain, headaches, dizziness, or fatigue.

It is advisable to avoid grapefruit juice while taking Pitavastatin 4.18 mg, as it can affect the medication's effectiveness.

Individuals with certain medical conditions, such as liver disease, or those who are pregnant or breastfeeding, should consult a healthcare provider before taking Pitavastatin 4.18 mg.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.